1Terada T,Kovacs K,Stefaneanu L,et al.Incidence,pathology,and recurrene of pituitary adenomas:study of 647 unselected surgical cases [J].Endocr Pathol,1995,6:301～310. 被引量：1
2Ciric I,Rosenblatt S,KerR W Jr,et al.Perspective in pituitary adenomas:an end of the century review of tumorigenesis,diagnosis and treatment [J].Clin Neurosurg,2002,47:99～111. 被引量：1
3Colao A,Annunziato L,Lombardi G.Treatment of prolactinomas [J].Ann Med,2003,30:452～459. 被引量：1
5Molitch ME.Medical treatment of prolactinoma [J].Endocrinol Metab Clin N Am,2002,28:142～169. 被引量：1
6Rees DA,Davies JS,Scanlon MF.Microprolactinoma:medical or surgical treatment as first line approach? The case for medical therapy [J].J Endocrinol Invest,2001,23:122～124. 被引量：1
7Zacur HA.Indications for surgery in the treatment of hyperprolactinemia [J].J Reprod Med,2003,44(Suppl 12):1127～1231. 被引量：1
8Di Sarno A,Landi ML,Marzullo P,et al.The effect of quinagolide and cabergoline,two selective dopamine receptor type 2 agonists,in the treatment of prolactinomas [J].Clin Endocrinol (Oxf) 2002,53:53～60. 被引量：1
8Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) , 2006, 65 : 265-273. 被引量：1
9Gillam MP, Molitch ME, Lombardi G, et al . Advances in the treatment of prolactinomas. Endocr Rev, 2006, 27 : 485-534. 被引量：1
10Losa M, Mortini P, Barzaghi, et al. Surgical treatment of prolactin-secreting pituitary adenoma: Early results and long-term outcome. J Clin Endocrinol Metab,2002, 87: 3180-3186. 被引量：1
